[HTML][HTML] Cancer vaccines: the next immunotherapy frontier
MJ Lin, J Svensson-Arvelund, GS Lubitz, A Marabelle… - Nature cancer, 2022 - nature.com
After several decades, therapeutic cancer vaccines now show signs of efficacy and potential
to help patients resistant to other standard-of-care immunotherapies, but they have yet to …
to help patients resistant to other standard-of-care immunotherapies, but they have yet to …
[引用][C] Cancer vaccines: the next immunotherapy frontier
MJ Lin, J Svensson-Arvelund, GS Lubitz, A Marabelle… - Nature Cancer, 2022 - cir.nii.ac.jp
Cancer vaccines: the next immunotherapy frontier | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
Cancer vaccines: the next immunotherapy frontier.
MJ Lin, J Svensson-Arvelund, GS Lubitz… - Nature Cancer, 2022 - europepmc.org
After several decades, therapeutic cancer vaccines now show signs of efficacy and potential
to help patients resistant to other standard-of-care immunotherapies, but they have yet to …
to help patients resistant to other standard-of-care immunotherapies, but they have yet to …
Cancer vaccines: the next immunotherapy frontier
MJ Lin, J Arvelund, GS Lubitz, A Marabelle… - NATURE …, 2022 - diva-portal.org
Brody and colleagues discuss the current status and potential of cancer vaccines,
highlighting challenges and opportunities to advance promising candidates to the clinic …
highlighting challenges and opportunities to advance promising candidates to the clinic …
Cancer vaccines: the next immunotherapy frontier
MJ Lin, J Svensson-Arvelund, GS Lubitz… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
After several decades, therapeutic cancer vaccines now show signs of efficacy and potential
to help patients resistant to other standard-of-care immunotherapies, but they have yet to …
to help patients resistant to other standard-of-care immunotherapies, but they have yet to …